Advertisement
New Zealand markets close in 55 minutes

  • NZX 50

    11,875.09
    +71.81 (+0.61%)
     

  • NZD/USD

    0.5943
    +0.0009 (+0.15%)
     

  • NZD/EUR

    0.5548
    +0.0007 (+0.12%)
     

  • ALL ORDS

    7,955.40
    +17.50 (+0.22%)
     

  • ASX 200

    7,700.50
    +17.00 (+0.22%)
     

  • OIL

    83.45
    +0.09 (+0.11%)
     

  • GOLD

    2,339.90
    -2.20 (-0.09%)
     

  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     

  • DAX

    18,137.65
    +276.85 (+1.55%)
     

  • Hang Seng

    17,080.29
    +251.36 (+1.49%)
     

  • NIKKEI 225

    38,390.44
    +838.28 (+2.23%)
     

  • NZD/JPY

    91.9410
    +0.1750 (+0.19%)
     

AI in Diagnostics Market to hit US $4,687 million by 2028 - Global Insights on Trends, Growth Drivers, Macroeconomic Indicators, COVID-18 Impact Analysis, Key Players and Future Opportunities: Adroit Market Research

Adroit Market Research
·4-min read

North America holds the largest share of market this is due to the increasing acceptance in clinical diagnosis of medical IT solutions, the advent of a very well-established healthcare industry, and high financing for AI-based diagnostic software growth

Dallas, Texas, Nov. 25, 2020 (GLOBE NEWSWIRE) -- The “Global AI in Diagnostics Market, by Component (Software, Hardware, Services), Application (Cardiology, Oncology, Pathology, Radiology, Chest and Lung, Neurology, and Others) Region (North America, Europe, Asia Pacific, Middle East and Africa, Latin America), Global Forecast, 2018 to 2028” study provides an elaborative view of historic, present and forecasted market estimates.

Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1703

Adroit Market Research report on AI in Diagnostics market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities, and challenges. The market has been studied for historic as 2018, with the base year of estimation as 2019 and forecast from 2020 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the market competition with company positioning based on their product portfolio, geographic footprint, strategic initiatives and overall revenue.

ADVERTISEMENT

The AI in Diagnostics market was valued at USD 412.8 million in 2020 and is expected to grow at a CAGR of 35.5% over the forecast period from 2020 to 2028. The rise in the number of diagnostic start-ups in healthcare Artificial Intelligence (AI) coupled with enormous investments by venture capitalist companies to develop innovative technologies that allow fast and efficient diagnostic procedures due to the continuous increase in the number of patients suffering from chronic diseases supports the growth of the market.

Browse the full report with Table of Contents and List of Figures at https://www.adroitmarketresearch.com/industry-reports/ai-in-diagnostics-market

Prominent players operating in the global AI in Diagnostics market have been studied in detail.

North America presently has the largest share of the AI in Diagnostics market owing to increasing adoption of new technologies. Asia Pacific is projected to offer the most robust growth, owing, among other things, to the continuous development of healthcare infrastructure and to awareness-raising in emerging economies such as India, Japan and China.

Purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1703

The global AI in Diagnostics market has been bifurcated based on type, application, and region. In terms of application the market is divided into Gastroenterological Procedures, Urological Procedures, Intervention Cardiology & Radiology, Peripheral Vascular Procedures, and Others. The global AI in Diagnostics market has been bifurcated based on component, application and region. In terms of Component the market is divided into Software, Hardware, Services. On the basis of application, the segment is divided into Cardiology, Oncology, Pathology, Radiology, Chest and Lung, Neurology, and Others.

Key players serving the global market include Aidoc, AliveCor, GE Healthcare, Imagen Technologies, Vuno Inc., IDx Technologies Inc., Siemens Healthcare GmbH, Neural Analytics, Riverain Technologies, Zebra Medical Vision, among other prominent players.

Are you looking for a DISCOUNT? If yes, then get in touch with us at https://www.adroitmarketresearch.com/contacts/discount/1703

Major Points from Table of Contents:
Chapter 1. Introduction
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. Global AI in Diagnostics Market by Component, 2018-2028 (USD Million)
Chapter 5. Global AI in Diagnostics Market by application, 2018-2028 (USD Million)
Chapter 6. Global AI in Diagnostics Market by Region, 2018-2028 (USD Million)
Chapter 7. Company Profiles
Chapter 8. Appendix

Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html

About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 972-362 -8199
Connect with us: Facebook | Twitter | LinkedIn